Research - Guelph, Ontario, Canada
Glysantis Inc is a pre-clinical stage company involved in the research and development of therapeutics based on a proprietary nanoparticle technology platform called NanoDendrix. Key areas of focus are immunomodulation and targeted drug delivery.
Outlook
Google AdSense
Mobile Friendly
Google Cloud Hosting